Company Profile
Hemmo Pharma is a leading manufacturer of Peptide-based pharmaceuticals, supplying quality products for the last 37 years. A private company, it has continuously been ranked as the leading supplier of bulk Oxytocin to the global market. Established in Mumbai (Bombay), India in 1967, the company has evolved into a global supplier of quality peptide products. With more than 75,000 square feet of manufacturing capacity and a large number of highly qualified scientists, the company manufacturers a wide variety of therapeutic and research peptides.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Bivalirudin |
128270-60-0 | - / 90% | Inquiry | |
Cosyntropin |
L-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO;cosyntropin;H-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG PRO-VAL-LYS-VAL-TYR-PRO-OH TETRACOSACTIDE (HUMAN, BOVINE, MOUSE, OVINE, PORCINE, RABBIT, RAT);H-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-OH;SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO HUMAN;SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO;TETRACOSACTIDE;TETRACOSACTIDE (HUMAN) |
16960-16-0 | - / 90% | Inquiry |
Octreotide |
SANDOSTATIN;SMS-201-995;[r-(r*,r*)]-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;OCTREOTIDE;OCTREOTIDE (SMS 201-995), ACETATE;cyclic(2-7)-disulfide,(r-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl);d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-cysteinamid;r*))-(racetate(salt) |
79517-01-4 | - / 93% | Inquiry |
Somatostatin |
Somatostatin;Growth hormone release-inhibiting factor;Somatotropin release-inhibiting factor;SRIF;AY 24910;Growth hormone release-inhibiting hormone;Somatostatin-14;Panhibin;Somatotropin release-inhibiting hormone;SIF;Aminopan;Somiaton;SRIF 14;GH-RIF;Somastin Sb;1: PN: WO2014070965 PAGE: 35 claimed sequence;52500-64-8;53126-12-8;56451-83-3 |
51110-01-1 | - / 93% | Inquiry |
Terlipressin |
[N-α-Triglycyl-8-lysine]-vasopressin;130: PN: WO2010033207 SEQID: 171 claiMed protein;1-Triglycyl-8-lysine Vasopressin;Nα-Glycyl-glycyl-glycyl-[8-lysine]-vasopressin;Nα-Glycyl-glycyl-glycyl-lysine-vasopressin;Nα-Glycylglycylglycyl-vasopressin;Nα-Gly-Gly-Gly-8-Lys-vasopressin;Triglycyl-8-lysine-vasopressin |
14636-12-5 | - / 95% | Inquiry |
CONTACT INFORMATION
Sign In for Details